| http://www.w3.org/ns/prov#value | - Switching away from tNRTIs to other NRTIs such as abacavir and tenofovir has been investigated as a therapeutic option for HIVLD and have resulted in both increases in subcutaneous fat [114] and improvements in dyslipidemia [115].Switching from tNRTI to tenofovir appears to have more favourable effects on lipids than switching from tNRTI to abacavir, though the overall lipid improvements are often
|
